Name | 1,4-dihydrobenzo[g]quinoxaline-2,3-dione |
---|
Molecular Formula | C12H8N2O2 |
---|---|
Molecular Weight | 212.20400 |
Exact Mass | 212.05900 |
PSA | 65.72000 |
LogP | 1.36960 |
~81% 186666-52-4 |
Literature: Bristol-Myers Squibb Company Patent: US6869956 B2, 2005 ; |
~% 186666-52-4 |
Literature: State of Oregon, acting by and through the Oregon State Board of Higher Education, acting for and on behalf of the Oregon Health Sciences University and the University of Oregon, Eugene Oregon; Acea Pharmaceuticals, Inc.; The Regents of the University of California Patent: US5631373 A1, 1997 ; |
~82% 186666-52-4 |
Literature: Oxtoby, Neil S.; Blake, Alexander J.; Champness, Neil R.; Wilson, Claire Chemistry - A European Journal, 2005 , vol. 11, # 16 p. 4643 - 4654 |
~% 186666-52-4 |
Literature: Friedlaender; Zakrzewski Chemische Berichte, 1894 , vol. 27, p. 764 |
~% 186666-52-4 |
Literature: Goldstein; Streuli Helvetica Chimica Acta, 1937 , vol. 20, p. 650,653 |